Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Current Assets: 2009-2024

Historic Current Assets for Gyre Therapeutics (GYRE) over the last 15 years, with Dec 2024 value amounting to $64.8 million.

  • Gyre Therapeutics' Current Assets rose 79.85% to $98.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.6 million, marking a year-over-year increase of 79.85%. This contributed to the annual value of $64.8 million for FY2024, which is 13.22% up from last year.
  • According to the latest figures from FY2024, Gyre Therapeutics' Current Assets is $64.8 million, which was up 13.22% from $57.2 million recorded in FY2023.
  • Gyre Therapeutics' Current Assets' 5-year high stood at $89.5 million during FY2020, with a 5-year trough of $49.7 million in FY2022.
  • In the last 3 years, Gyre Therapeutics' Current Assets had a median value of $57.2 million in 2023 and averaged $57.2 million.
  • As far as peak fluctuations go, Gyre Therapeutics' Current Assets plummeted by 42.49% in 2021, and later increased by 15.24% in 2023.
  • Yearly analysis of 5 years shows Gyre Therapeutics' Current Assets stood at $89.5 million in 2020, then slumped by 42.49% to $51.5 million in 2021, then declined by 3.54% to $49.7 million in 2022, then rose by 15.24% to $57.2 million in 2023, then grew by 13.22% to $64.8 million in 2024.